PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
165.94%
Net income growth above 1.5x CRK's 0.97%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
13.17%
Some D&A expansion while CRK is negative at -64.47%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-98.43%
Negative yoy deferred tax while CRK stands at 103.03%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-132.14%
Negative yoy SBC while CRK is 9.06%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
87.10%
Slight usage while CRK is negative at -130.67%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
97.78%
AR growth well above CRK's 134.84%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-121.43%
Both reduce yoy usage, with CRK at -99.06%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-228.57%
Negative yoy while CRK is 131.72%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
3.25%
Some CFO growth while CRK is negative at -74.29%. John Neff would note a short-term liquidity lead over the competitor.
0.20%
Lower CapEx growth vs. CRK's 3.19%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-22.73%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
100.00%
Liquidation growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
95.09%
Growth well above CRK's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-2.58%
We reduce yoy invests while CRK stands at 3.19%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-4.76%
We cut debt repayment yoy while CRK is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.